David Shaw’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$53.8K Buy
+12,494
New +$59.2K ﹤0.01% 4761
2022
Q4
– Sell
-457,874
Closed -$4.55M – 5126
2022
Q3
$4.55M Buy
457,874
+60,368
+15% +$597K 0.01% 2206
2022
Q2
$3.91M Buy
397,506
+204,867
+106% +$2.01M ﹤0.01% 2426
2022
Q1
$1.89M Buy
192,639
+74,339
+63% +$734K ﹤0.01% 3356
2021
Q4
$1.17M Hold
118,300
– – ﹤0.01% 3800
2021
Q3
$1.18M Buy
+118,300
New +$1.16M ﹤0.01% 3478

Other funds holding TLSI

David Shaw's TLSI Position: Q3 2026 in Review

David Shaw opened a new position in TriSalus Life Sciences (TLSI) in Q3 2026: 12,494 shares worth $53.8K. The stake represents ﹤0.01% of the portfolio and ranks #4761 among its holdings. This is a return to the name: David Shaw previously reported a position in TLSI as recently as Q3 2022.

David Shaw first reported a position in TLSI in Q3 2021 and has held it in 6 quarters since. The position peaked at $4.55M in Q3 2022. 82 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

  • David Shaw held 12,494 shares of TriSalus Life Sciences worth $53.8K as of Q3 2026.
  • TriSalus Life Sciences was a new David Shaw position in Q3 2026.
  • TriSalus Life Sciences made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4761 holding.
  • David Shaw first reported a position in TriSalus Life Sciences in Q3 2021 and has held it in 6 quarters since.
  • David Shaw's TriSalus Life Sciences position peaked at $4.55M in Q3 2022.
  • 82 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.